SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Novavax (NVAX)

NVAX RSS Feed
Add NVAX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 12/16/2017 4:07:39 PM - Followers: 216 - Board type: Free - Posts Today: 0

ABOUT NOVAVAX:

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates. In addition, the company is developing its vaccine candidates for worldwide commercialization including:

Our world-class scientific team is using VLP technology to tackle influenza viruses – including avian strains that have the potential to cause a pandemic outbreak. Our team has created vaccine candidates that are in various phases of clinical testing designed to protect against various circulating strains of pandemic influenza including H1N1 and H5N1, as well as seasonal influenza. Our recombinant nanoparticle protein micelle technology targeted at RSV has been tested in various preclinical studies and has now advanced into clinical testing.

Our vision is to control the spread of infectious diseases by using a unique single-use manufacturing system that allows for the rapid mass production of recombinant protein nanoparticle vaccines. Our goal is to be able to rapidly deliver a customized vaccine in the midst of a declared pandemic.
 


MANAGEMENT TEAM:

President and Chief Executive Officer
Stanley C. Erck

Senior Vice President, Research and Development
Gregory M. Glenn, M.D.

Senior Vice President, Manufacturing and Process Development
Timothy J. Hahn, Ph.D.

Senior Vice President, Chief Financial Officer and Treasurer
Barclay A. "Buck" Phillips

Senior Vice President, Business Development
Russell P. "Rip" Wilson

Vice President, Regulatory Affairs
Amy B. Fix

Vice President, Chief Medical Officer
Louis F. Fries III, M.D.

Vice President, Manufacturing
Mervyn L. Hamer

Vice President, General Counsel and Corporate Secretary
John A. Herrmann III, J.D.

Vice President, Process Development
Erica Shane, Ph.D.

Vice President, Vaccine Development
Gale Smith, Ph.D.

Vice President, Clinical Operations
D. Nigel Thomas, Ph.D.

 

CLINICAL-STAGE PIPELINE:

Novavax’s clinical program includes vaccine candidates designed to address infectious diseases worldwide. Using innovative virus-like particle (VLP) and recombinant nanoparticle technology, as well as new and efficient manufacturing approaches, the company produces vaccine candidates to combat diseases, with the goal of allowing countries to better prepare for and more effectively respond to rapidly spreading infections. Our clinical pipeline is shown below.

 
ADJUVANT PIPELINE:

 

 
CHARTS:



 


LINKS:

http://www.novavax.com/
http://finance.yahoo.com/q/h?s=NVAX
http://www.novavax.com/download/File/Interphex.pdf
http://www.sec.gov/cgi-bin/browse-edgar?company=Novavax&CIK=&filenum=&State=&SIC=&owner=include&action=getcompany
http://www.wipo.int/pctdb/en/wo.jsp?WO=2008061243

 
SureTrader
Interactive Brokers Advertisement
NVAX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NVAX News: Analysis: Positioning to Benefit within Aradigm, General Motors, AT&T, Denbury Resources, Novavax, and Immunomedics — Resea... 11/27/2017 08:05:00 AM
NVAX News: Statement of Changes in Beneficial Ownership (4) 11/13/2017 08:16:53 AM
NVAX News: Statement of Changes in Beneficial Ownership (4) 11/13/2017 08:15:03 AM
NVAX News: Novavax to Present at the Stifel 2017 Healthcare Conference 11/08/2017 04:05:24 PM
NVAX News: Novavax to Present at the Stifel 2017 Healthcare Conference 11/08/2017 04:05:00 PM
PostSubject
#4997   NVAX About to SOAR. Investors in Novavax, Inc. Mrtatham 12/16/17 04:07:39 PM
#4996   Did you catch the 9mil share buy right Lone Wolf 12/16/17 08:50:41 AM
#4995   Very high volume 19+ mil. Getting popular around here Dgoff 12/16/17 05:41:46 AM
#4994   We've been getting clobbered the last couple of leftovers 12/13/17 12:02:03 PM
#4993   thanks bleu22. Interesting....Great opportunity to add. the gipper 12/12/17 04:55:52 PM
#4992   Options are up on the 15th, and calls bleu22 12/11/17 03:42:39 PM
#4991   Could be a big week for biotechs....Bluebird up the gipper 12/11/17 09:31:03 AM
#4990   All biotech pretty much looks to b down bleu22 12/06/17 11:47:01 AM
#4989   Its gone up. Now its time to go AVALANCHE06 12/06/17 11:32:13 AM
#4988   Just peeps trying to get cheaper shares before imapro 12/06/17 11:21:23 AM
#4987   Supposed to go up not down. What’s going on? Dgoff 12/06/17 11:17:11 AM
#4986   IBB had 3-1 split bleu22 12/01/17 10:39:52 AM
#4985   Busting a move today imapro 12/01/17 09:53:28 AM
#4984   A coincidence worth the wait! leftovers 11/30/17 03:53:39 PM
#4983   I agree bleu22 11/30/17 03:09:56 PM
#4982   CEO bought 100,000 shares 11/13/17 must wait 30 imapro 11/30/17 02:50:45 PM
#4981   you seem to know the news already! pankajanc 11/30/17 02:33:41 PM
#4980   Going $2+ once News breaks next couple weeks imapro 11/30/17 10:29:40 AM
#4979   * * $NVAX Video Chart 11-29-17 * * ClayTrader 11/29/17 04:26:39 PM
#4978   Could apply to Prepare™... chrismiss_everyday 11/29/17 11:18:37 AM
#4977   Punch through it BULLS!!! Dgoff 11/29/17 09:58:54 AM
#4976   Shorts doing what they do. Dgoff 11/29/17 09:57:40 AM
#4975   * * $NVAX Video Chart 11-28-17 * * ClayTrader 11/28/17 04:53:32 PM
#4974   It has been an impressive 2 weeks...these guys Gup80 11/28/17 03:12:23 PM
#4973   * * $NVAX Video Chart 11-27-17 * * ClayTrader 11/27/17 05:04:29 PM
#4972   Bought back in 1.40 don estaban 11/27/17 11:57:28 AM
#4971   $197,000.00 by @ 1.41! Wow, that is the gipper 11/27/17 11:53:12 AM
#4970   Dropped 15k @ 1.53 still have 7 k don estaban 11/27/17 11:23:51 AM
#4969   I was one Jacob76 11/27/17 10:59:59 AM
#4968   Lots of stops just got blown out bleu22 11/27/17 10:19:25 AM
#4967   Upcoming nano results and barda virtually make that bleu22 11/27/17 08:28:12 AM
#4966   Novavax, Inc. (NVAX) REPORT OVERVIEW Novavax's Recent Financial Performance F WovenO2 11/27/17 08:12:08 AM
#4965   I'm up 29-cents a share, up and out :-) Saskey 11/26/17 02:12:33 PM
#4964   Also NANO data should be coming out very Hazerk 11/25/17 03:13:56 PM
#4963   Nice!! Lock em up at 4.00 and just Hazerk 11/25/17 02:37:56 PM
#4962   Own now 22k @ 1.22 $4 a don estaban 11/25/17 02:19:00 PM
#4961   Shares are already up for sale at 4.00 Hazerk 11/25/17 02:08:32 PM
#4960   Hope your right don estaban 11/25/17 01:42:56 PM
#4959   I’m in at 1.60 and looking for 4.00 here Hazerk 11/25/17 12:56:28 PM
#4958   Huge day yesterday day for NVAX volume explosive. the gipper 11/25/17 11:36:01 AM
#4957   * * $NVAX Video Chart 11-24-17 * * ClayTrader 11/24/17 02:06:31 PM
#4956   Nice support on that 1.54 bleu22 11/24/17 01:00:42 PM
#4955   Picked up another block today I have been/was MrRhino 11/24/17 12:40:15 PM
#4954   Utterly astonishing volume---5.3 mll the day after Thanksgiving??!!!Volume the gipper 11/24/17 12:11:33 PM
#4953   Looks like TUTES have definitely showed up. GLTA bleu22 11/24/17 11:17:59 AM
#4952   Nice accumulation! sorkin 11/24/17 11:13:50 AM
#4951   Hopefully setting up for some big news !!! don estaban 11/24/17 10:45:23 AM
#4950   Another amazing week! Santo 11/24/17 10:43:07 AM
#4949   If the RSV study goes well, and the the gipper 11/22/17 06:11:42 PM
#4948   I’ll take 5-10 three years out :-) WovenO2 11/22/17 04:38:42 PM
PostSubject